$ cat ./records/gates-foundation-co-funds-cepi-at-davos-to-accelerate-epidemic-va-2017.txt
Gates Foundation Co-Funds CEPI at Davos to Accelerate Epidemic Vaccines
[RECORD.TXT] · cat --full
At the World Economic Forum in Davos, the Bill & Melinda Gates Foundation co-founded the Coalition for Epidemic Preparedness Innovations (CEPI) alongside the Wellcome Trust and the governments of Norway, Japan, Germany, and India, with $460 million in initial funding. CEPI's mandate was to fund and coordinate the development of vaccines against emerging epidemic diseases — including work that would later accelerate COVID-19 mRNA vaccine candidates — so that vaccines could be ready within 16 weeks of a new pathogen being identified.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Awards $11 Million to FAO for African Food and Agriculture Policy
Next →
Gates Foundation significantly expanded its MENA humanitarian refugee response to over $20 million
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.